News Coronavirus EMA starts rolling review of remdesivir for COVID-19

EMA starts rolling review of remdesivir for COVID-19

EMA’s human medicines committee (CHMP) has started a ‘rolling review’ of data on the use of the investigational antiviral medicine remdesivir for the treatment of coronavirus disease (COVID-19).

The start of the rolling review only means that the evaluation of remdesivir has started and does not imply that its benefits outweigh its risks.

A rolling review is one of the regulatory tools available to the Agency to speed up the assessment of a promising investigational medicine during a public health emergency, such as the ongoing pandemic.

Under normal circumstances, all data supporting a marketing authorisation application must be submitted at the start of the evaluation procedure. In the case of a rolling review, CHMP Rapporteurs are appointed whilst development is still ongoing and the Agency reviews data as they become available.

Several rolling review cycles can be carried out during the evaluation of one product as data continue to emerge, with each cycle lasting around two weeks depending on the amount of data to be assessed. Once the data package is complete, the developer submits a formal marketing authorisation application which is then processed under a shortened timetable.

While the overall review timeline for remdesivir cannot be anticipated at this moment, it is expected that this procedure will allow EMA to complete its assessment significantly earlier compared with a regular evaluation procedure, while still ensuring a robust scientific opinion is reached.

The CHMP’s decision to start the rolling review of remdesivir is based on preliminary results from the ACTT study, which suggest a beneficial effect of remdesivir in the treatment of hospitalised patients with mild-to-moderate or severe COVID-19. However, EMA has not yet evaluated the full study and it is too early to draw any conclusions regarding the benefit-risk balance of the medicine.

Any new data that becomes available for evaluation during this rolling review need to be considered in the context of all other existing data. The CHMP will evaluate all data on remdesivir, including evidence from a recently published study from China and other clinical trials and conclude on the medicine’s benefits and risks as soon as possible.

Although remdesivir is not yet authorised in the European Union, it is available to patients through clinical trials and so-called ‘compassionate use’ programmes through which patients can get access to unauthorised medicines in emergency situations.

More about the medicine

Remdesivir is an antiviral medicine which is being investigated for the treatment of COVID-19. Remdesivir is a ‘viral RNA polymerase inhibitor’ (a medicine that interferes with the production of viral genetic material, preventing the virus from multiplying). It has shown broad in vitro activity against different RNA viruses, including SARS-CoV-2 and was originally developed for the treatment of Ebola virus disease.

Remdesivir is being developed by Gilead Sciences Ireland CU and is given by infusion (drip) into a vein.

Information on compassionate use for remdesivir in the EU is available.

Top Stories

11 new Covid cases in Cyprus, number steadily down, tests rising

  11 new cases of Covid-19 were announced today in Cyprus, out of a total of 3,314 diagnostic tests, taking the total number to 1233. New...

Police fire tear gas at Beirut protesters furious after explosion

  Lebanese riot police fired tear gas at demonstrators trying to break through a barrier to get to the parliament building in Beirut during a...

82 year old killed in Paphos while trying to move his car off the pavement-victim named

  An 82 year old man was killed this morning in Paphos, as he was trying to move his car away from a pavement near...

Paphos fire has scorched 5 square kilometres, still raging, destruction ‘biblical’ (update)

  A fire that broke out early this morning near the Paphos community of Archimandrita and spread on a 20 kilometre front near the villages...

Brazil COVID-19 deaths reach 100,000 and barrel onward

  Brazil’s death toll from COVID-19 is expected to hit 100,000 today and continue to climb as most Brazilian cities reopen shops and dining even...

Taste

Octopus ‘Kathisto’ (or Octopus braised in Wine)

Ingredients: 1/2 cup Greek extra virgin olive oil 2 medium onions, chopped fine 1 large octopus, about 2kg (cleaned and kept whole) 3/4 cup dry red wine 1/3 cup...

Homemade lemonade

Ingredients: 1 cup lemon juice 1 cup sugar Method: Thoroughly wash the lemons with soap and warm water. Roll each lemon with the palm of your hand, pressing...

‘Striftaria’ mini cheese pies

Ingredients 1 ½ cup milk 2 tbsps. flour 4 tsps. of butter 3 eggs, slightly beaten + 1 extra with 1 tbs. of milk for spreading 1 pack of...

Mini potato canapes baked on salt

Ingredients Serves: 12 1kg small Cypriot potatoes rock salt, as needed 250g salted butter 300ml full fat cremé frâiche 1 pot cod or salmon roe Method Prep:20min › Cook:35min › Ready in:55min Take...